CSIMarket
 
Vivani Medical Inc   (VANI)
Other Ticker:  
 
 
Price: $1.4400 $0.07 5.109%
Day's High: $1.45 Week Perf: 11.63 %
Day's Low: $ 1.37 30 Day Perf: 12.5 %
Volume (M): 240 52 Wk High: $ 7.80
Volume (M$): $ 346 52 Wk Avg: $1.40
Open: $1.37 52 Wk Low: $0.84



 Market Capitalization (Millions $) 80
 Shares Outstanding (Millions) 55
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -23
 Cash Flow (TTM) (Millions $) -5
 Capital Exp. (TTM) (Millions $) 1

Vivani Medical Inc
Vivani Medical Inc is a healthcare company that specializes in medical devices and equipment. They develop and manufacture advanced medical products to meet the needs of healthcare professionals and patients. The company focuses on innovative technologies and solutions to improve patient care and help healthcare providers deliver better outcomes. Vivani Medical Inc is committed to continually research, develop, and produce high-quality medical products that meet rigorous standards and regulations. Their product portfolio includes a wide range of medical devices, such as diagnostic equipment, monitoring systems, and therapeutic devices. The company aims to contribute to the advancement of healthcare by providing innovative and reliable solutions for various medical needs.


   Company Address: 1350 S. Loop Road Alameda 94502 CA
   Company Phone Number: 506-8462   Stock Exchange / Ticker: NASDAQ VANI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DRIO   -13.59%    
DXCM        3.59% 
MDT        0.71% 
PODD        0.53% 
TNDM   -0.36%    
UBI   -0.36%    
• View Complete Report
   



Business Update

Vivani Medical Propels Forward with $5M Boost and Novel Drug Implant Progress,

Published Wed, Nov 13 2024 2:36 PM UTC

Vivani Medical Advances Innovative Drug Implants Amidst Strong Financial Backing Alameda, Calif. - In a compelling combination of scientific progress and strategic financial maneuvers, Vivani Medical, Inc. (Nasdaq: VANI), a leader in the development of miniaturized, long-acting drug implants, has unveiled its third-quarter financial results for 2024, alongside a noteworthy b...

Business Update

title Vivani Medicals Miniature Obesity Implant A Game-Changing Breakthrough in Chronic Weight Management

Published Thu, Jul 11 2024 1:21 PM UTC

Vivani Medical Sets Sights on Breakthrough Miniature Obesity Implant ProgramALAMEDA, Calif. - Vivani Medical, Inc. (Nasdaq: VANI), a pioneering biopharmaceutical company specializing in long-term drug implants, recently provided an update on its clinical development plans for the NPM-115 program. This innovative initiative aims to tackle the pressing issue of chronic weight ...

Business Update

Vivani Medical Receives FDA Clearance and Lifts Clinical Hold for Revolutionary Miniature Subdermal GLP-1 Drug Implant

Published Thu, Jun 13 2024 12:47 PM UTC

Vivani Medical, a pioneering biopharmaceutical company based in Alameda, California, has announced a significant breakthrough in the field of long-term drug implants. The U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) and lifted the clinical hold on NPM-119, Vivani's groundbreaking miniature long-term subdermal GLP-1 drug i...

Business Update

Vivani Medical Unveils Breakthrough in Feline Healthcare: Innovative OKV-119 Implant Sh...

Published Tue, May 28 2024 2:38 PM UTC

Pioneering the Future of Veterinary Medicine: Vivani Medical Announces Landmark Progress in Combatting Feline Obesity with Innovative OKV-119 Implant'In a remarkable stride towards revolutionizing the realm of veterinary medicine, Vivani Medical, Inc. (Nasdaq: VANI), a cutting-edge biopharmaceutical company renowned for developing miniaturized, long-term drug implants, has h...

Business Update

Vivani Medical Leaps Forward in Chronic Weight Management Solutions with Promising Financial Results

Published Tue, May 14 2024 4:03 AM UTC

Vivani Medical Reports First Quarter 2024 Financial Results and Provides Business UpdateALAMEDA, Calif. - Vivani Medical, Inc. (Nasdaq: VANI), a leading biopharmaceutical company specializing in the development of miniaturized, long-term drug implants, released its financial results for the first quarter of 2024 and provided an update on its business operations. The company'...










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com